UCLB becomes first leading academic institution Partner of One Nucleus

14 November 2011

UCLB, the technology transfer and commercialisation arm of University College London (UCL), has joined forces with One Nucleus to bring the benefits of One Nucleus Gold membership to departments across UCL. 

Under the One Nucleus Partner programme, UCLB and UCL Departments will be able to access a range of networking and training opportunities aimed at profile raising and will be able to take advantage of the One Nucleus group purchasing scheme.

Both UCLB and One Nucleus are committed to playing an active and supportive role in assisting in the success of the life sciences sector in the London area and beyond.

Anne Lane, Executive Director of UCLB commented, “UCLB plays a pivotal role in UCL’s interactions with the global life sciences sector. The One Nucleus activities locally and through their international relationships provide an excellent platform for UCLB to deliver these benefits to our parent university”.

Harriet Fear, CEO of One Nucleus said, “Our Partner Programme is a bespoke package of support for large organisations and companies central to the success of the sector. We are delighted that UCLB is becoming a Partner, leading the engagement for UCL with our members and wider audience”.

One Nucleus is a not-for-profit membership organisation for international life science and healthcare companies — the largest of its kind in Europe. It was formed from the merger of ERBI and the London Biotechnology Network in 2010. The 450 members include pharmaceutical, biotech, medical device and diagnostic companies and associated technical and commercial service providers.